Skip to main content
Clinical Trials/CTRI/2020/03/023868
CTRI/2020/03/023868Not yet recruitingNot Applicable

Study of serum uric acid in essential hypertension:In a tertiary care hospital

DR Parth Vhora1 site in 1 country108 target enrollmentStarted: October 3, 2020Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
108
Locations
1
Primary Endpoint
Serum uric acid has a positive correlation with essential hypertension.

Study Overview

Brief Summary

Serum uric acid serves as a prognostic marker in the pathogenesis of hypertension. It serves as a prognostic marker in the complications of essential hypertension like diabetes and cardiovascular diseases.By measuring serum uric acid in essential hypertensives and comparing it with normotensive subjects,a association between essential hypertension and serum uric acid can be established.Essential hypertension has many modifiable  risk factors but there is a need to identify additonal risk factors like serum uiric acid to prevent complications and pathogenesis of essential hypertension. My study hopes to find this association between essential hypertension and serum uric acid levels.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18.00 Year(s) to 90.00 Year(s) (—)
Sex
All

Inclusion Criteria

  • •Only essential hypertensives will be taken for the study Controls will be age and sex matched to the cases.

Exclusion Criteria

  • •Secondary causes of hypertension Gout All Leukaemias Polycythemia Chronic obstructive pulmonary disease Tuberculosis Chronic kidney disease Type 2 diabetes mellitus Drugs Causing Hyperuricaemia –Thiazide diuretic,Loop diuretics.

Outcomes

Primary Outcomes

Serum uric acid has a positive correlation with essential hypertension.

Time Frame: serum uric acid levels will be assesed at the end of 1 YEAR in essential hypertensives and compared with controls.

Higher grade of hypertension is associated with higher serum uric acid levels.

Time Frame: serum uric acid levels will be assesed at the end of 1 YEAR in essential hypertensives and compared with controls.

Secondary Outcomes

  • Serum uric acid of essentail hypertensives will be compared with that of age and sex matched controls.(At 1 month intervals till 1 year.)

Investigators

Sponsor
DR Parth Vhora
Sponsor Class
Other [self]

Study Sites (1)

Loading locations...

Similar Trials